A practical guide to prescribing estrogen replacement therapy

Area of Science:

• Endocrinology
• Women's Health
• Cardiovascular Health

Background:

• Menopausal hormone replacement therapy is a common prophylactic treatment.
• Estrogen replacement therapy (ERT) is known to retard bone density loss and offer cardioprotective benefits.
• The addition of progestins to ERT is necessary to mitigate endometrial cancer risk.

Purpose of the Study:

• To investigate the long-term effects of ERT on various tissues.
• To examine the interaction between progestins and the beneficial effects of estrogen.
• To assess the impact of ERT on breast cancer risk and identify high-risk individuals.

Main Methods:

• Review of accumulated data on estrogen replacement therapy.
• Analysis of studies investigating the effects of progestins on ERT.
• Evaluation of metabolic changes associated with different ERT routes.

Main Results:

• ERT demonstrates cardioprotective effects and retards bone density loss.
• Progestins are essential to counteract the increased endometrial cancer risk associated with unopposed estrogen.
• Further research is needed to fully understand progestin's impact on lipoproteins and arterial wall effects, as well as breast cancer risks and route-specific metabolic changes.

Conclusions:

• Physicians must understand the comprehensive pros and cons of ERT for postmenopausal women.
• Optimizing ERT involves careful modulation of dose, route, and agent to enhance patient compliance.
• Patient education is crucial for maintaining motivation and adherence to hormone replacement therapy.